Health Affairs, 25, no. 1 (2006): 248-255 doi: 10.1377/hlthaff.25.1.248 © 2006 by Project HOPE	New Online   McAllen, TX & Beyond: An Expert Roundtable   Geography & Reform   Medicaid or Insurance Exchange?   Siren Song of New GME   Public Plan Option: Pro & Con

This Article Full Text (HTML) Reprint (PDF) Online Appendix Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Gellad, W. F. Articles by Haas, J. S. Search for Related Content PubMed PubMed Citation Articles by Gellad, W. F. Articles by Haas, J. S. Related Collections Access To Care Health Reform Medicare Business Of Health Pharmaceuticals Health Spending Consumer Issues Elderly

DataWatch

How The New Medicare Drug Benefit Could Affect Vulnerable Populations

This study estimates how out-of-pocket drug costs could change for vulnerable populations (racial and ethnic minorities, the near-poor, and seniors with a greater burden of chronic conditions) who qualify for the standard Medicare drug benefit. Although the new benefit might be associated with modest-to-moderate declines in out-of-pocket spending for seniors who do not qualify for subsidies, the savings might not be shared equitably and therefore might not reduce financial barriers to medication use for these populations.

                      What's this?

This article has been cited by other articles:

				K. Jones, C. Siegel, D. N. Bertollo, and J. Samuels Impact of the Medicare Modernization Act on Dually Eligible Persons With Psychiatric Diagnoses: A New York State Case Study Psychiatr Serv, April 1, 2009; 60(4): 512 - 519. [Abstract] [Full Text] [PDF]

				M. R. Gold, S. Sofaer, and T. Siegelberg Medicare And Cost-Effectiveness Analysis: Time To Ask The Taxpayers Health Aff., September 1, 2007; 26(5): 1399 - 1406. [Abstract] [Full Text] [PDF]

				P. Neuman, M. K. Strollo, S. Guterman, W. H. Rogers, A. Li, A. M. C. Rodday, and D. G. Safran Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors Health Aff., September 1, 2007; 26(5): w630 - w643. [Abstract] [Full Text] [PDF]

				S. B. Soumerai, M. Pierre-Jacques, F. Zhang, D. Ross-Degnan, A. S. Adams, J. Gurwitz, G. Adler, and D. G. Safran Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med, September 25, 2006; 166(17): 1829 - 1835. [Abstract] [Full Text] [PDF]

				U. D. Patel and M. M. Davis Falling into the Doughnut Hole: Drug Spending among Beneficiaries with End-Stage Renal Disease under Medicare Part D Plans J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2546 - 2553. [Abstract] [Full Text] [PDF]